Skip to search formSkip to main content

tebipenem

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Tebipenem (SPR859) is the microbiologically active form of SPR994 (tebipenem-pivoxil), an orally available carbapenem with… Expand
Is this relevant?
2017
2017
BackgroundThe carbapenem subclass of β-lactams is among the most potent antibiotics available today. Emerging evidence shows that… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2017
2017
BackgroundDifficult-to-treat infections caused by rapidly growing mycobacteria (RGM) are increasingly observed in clinical… Expand
  • table 1
  • table 2
Is this relevant?
2017
2017
AIM The objective of this study was to assess if avibactam, a new β-lactamase inhibitor, can restore the potency of carbapenems… Expand
Is this relevant?
2017
2017
Purpose. The aim of this study was to assess the in vitro efficacy of candidate antimicrobials against extended‐spectrum &bgr… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
The aim of this study was to determine the kinetic and thermodynamic parameters of tebipenem degradation in the solid state. The… Expand
Is this relevant?
2014
2014
We evaluated the antituberculosis (anti-TB) activity of five β-lactams alone or in combination with β-lactamase inhibitors… Expand
Is this relevant?
2013
2013
SM-295291 and SM-369926 are new parenteral 2-aryl carbapenems with strong activity against major causative pathogens of community… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
A inexpensive and rapid isocratic LC method has been developed for the quantitative determination of tebipenem—a new β-lactam… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2005
2005
The in vitro activity of tebipenem (TBM), a new oral carbapenem antibiotic, against Streptococcus pneumoniae clinical isolates (n… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?